Glycan Biosciences with its Platform Technology is focusing on developing compounds that can be made into safe and effective medicines for a range of inflammatory diseases, including orphan diseases. Diseases where currently therapies are not adequately improving the patient's health and quality of life are Glycan Biosciences' targets.


Many of these diseases are presently treated with corticosteroids. Corticosteroids act inside cells to decrease production of many growth factors, some of these growth factors are involved in inflammatory diseases but others are necessary for good bone and skin growth. As a result many patients are worried about the long term use of this class of medicine.


Glycan Biosciences' goal is to identify and synthesize Glycanics that can be developed into treatments that are safe.


Selected Glycanics can also be used in tissue engineering. Tissue engineering or regenerative medicine is a way of restoring, maintaining or enhancing tissue and organ function. The addition of appropriately designed Glycanics to present tissue engineering procedures will provide the chemical cues necessary for restoring cell growth and tissue function.


Glycanics have a broad application in human disease and regenerative medicine: –

Glycanics for inflammatory disease

  • Allergic Rhinitis

  • Anaphylaxis

  • Asthma

  • COPD

  • ARDS

  • Other inflammatory diseases

  • Orphan inflammatory diseases

  • Eczema


Glycanics for regenerative medicine

  • Wound healing

  • Tissue engineering

  • Liver cells

  • Muscle

  • Bone and cartilage

site policy terms & conditions © 2017 Glycan Biosciences LLC